Introduction
Monochorionic (MC) twin pregnancies are considered high-risk because of the potential to develop the morbid conditions of twin-twin transfusion syndrome (TTTS), twin anemia polycythemia sequence, or twin oligohydramniospolyhydramnios sequence.
1,2 Additionally, MC twins have a greater likelihood of developing selective intrauterine growth restriction (IUGR), and single and double intrauterine fetal death (IUFD) compared to dichorionic twins. 3 Consequently, international professional guidelines advise that all MC twin pregnancies undergo ultrasound assessment of fetal growth, amniotic fluid volume, and umbilical artery Doppler velocimetry every 2 weeks from 16 weeks' gestation. 4e6 However, the majority of MC twins will not develop any of these complications. 7 At present, no screening test is available to predict which MC twin pregnancy will develop complications and therefore all MC twins undergo the intensive antenatal surveillance that has an impact on patients and health care resources.
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Objectives We sought to assess the ability of firsttrimester pregnancyerelated factors (ultrasound measurements, maternal characteristics, biomarkers) to predict complications in MC twin pregnancies.
Materials and Methods
This systematic review was performed according to a protocol designed a priori and registered on PROSPERO (www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID¼CRD42015024975). It is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 8 
Eligibility criteria
Studies that reported ultrasound measurements, maternal characteristics, or potential biomarkers, measured in the first trimester (ie, up to 14 weeks' gestation), in MC-diamniotic twin pregnancies that provided sufficient information to assess the association between the variable and outcome were eligible for inclusion. Monochorionicity had to have been confirmed either by the presence of the T sign or absence of the l or twin peak sign on first-trimester ultrasound, 9 or postnatally by placental examination. Studies with <5 MC-diamniotic twin pregnancies were excluded, as were those pregnancies affected by: major structural or chromosomal anomalies, twin-reversed arterial perfusion, miscarriage, single IUFD <14 weeks' gestation, higher-order multiple, or monoamniotic pregnancies.
Potential prognostic factors
All first-trimester potential prognostic factors were included. Data were extracted using the same cut-offs as reported by the authors. For meta-analysis, thresholds were not combined (ie, crown-rump length [CRL] discordance >10% was not combined with CRL discordance >20%). Maternal age and body mass index (BMI) were analyzed as continuous variables. Maternal ethnicity was dichotomized to white and nonwhite to enable meta-analysis, parity was dichotomized to multiparous and nulliparous, maternal smoking was dichotomized to current smoker and nonsmoker with ex-smokers included in the nonsmoker group, and mode of conception was dichotomized to spontaneous or assisted reproductive technology.
Outcomes
The outcomes evaluated were: TTTS, irrespective of whether treatment was required/performed, and according to definitions used by authors of individual studies (Supplementary Table) including significant discrepancy in intertwin amniotic fluid volumes as per Quintero et al. 10 Antenatal growth restriction (AGR) only, based on estimated fetal weight (EFW) (irrespective of the presence of umbilical artery Doppler abnormalities), as defined by each study. Postnatal growth restriction (PGR) only, based on birthweight as defined by each study, but if reported as intertwin discordance, must be !20%. AGR and PGR within the same pregnancy. AGR or PGR, which includes all the growth-restricted pregnancies in the other 3 growth restriction groups (AGR, PGR, antenatal and postnatal growth restriction within the same pregnancy). Single IUFD >14 weeks' gestation. Double IUFD >14 weeks' gestation.
Within our protocol the definitions of the outcomes were not prespecified to allow for variation of definitions. Where a definition exists, eg, Quintero for TTTS, !20% for antenatal growth discordance, this was adopted for decisions regarding inclusion of studies for meta-analysis. For those analyses where there was variation in definitions, sensitivity analysis was employed where possible to determine the effects of the definition on the results.
Information sources
Electronic databases were searched: MEDLINE, Embase, ISI Web of Science, CINAHL, the Cochrane Central Registration of Controlled Trials and Research Registers, and Google Scholar, from inception to May 12, 2017 . Gray literature was hand-searched and bibliographies of articles checked.
Search strategy
Key words and medical subject heading terms relating to the following were used: "twin-twin transfusion syndrome," "twin anemia polycythemia sequence," "twin oligohydramnios-polyhydramnios sequence," "fetal death," "intrauterine AJOG at a Glance Why was this study conducted? No prognostic test is currently available to predict which monochorionic twin pregnancies will develop twin-twin transfusion syndrome (TTTS), intrauterine growth restriction, or intrauterine fetal death.
Key Findings
Although a significant association was found between nuchal translucency >95th centile in one/both fetuses and TTTS, and crown-rump length discordance !10% and TTTS, both demonstrated poor individual prognostic ability.
What does this add to what is known?
We have revealed a lack of research investigating first-trimester biomarkers in monochorionic twin pregnancies. Different assessment methods and definitions of each variable and outcome were an issue and this highlights the need for a large cohort study to evaluate these factors.
ajog.org Systematic Reviews growth restriction," "diseases in twins," "amniotic fluid," "placenta," "biomarkers," "ultrasonographic markers and prediction"; and combined with "monochorionic" and "twins" (Appendix A).
Study selection and data extraction
Articles to be included in the review were selected by 2 reviewers (F.L.M., M.J.H.) independently in a 2-stage process; the first being review of titles and abstracts for selection for the second stage of full article review. Where there was disagreement, consensus was reached by a third reviewer (R.K.M.). There was no restriction on language or study design. Abstracts were included if there was sufficient information to assess the study quality and association between the variable and the outcome. 
Quality assessment of included studies
The quality of the studies was assessed by F.L.M. and M.J.H. using the Strengthening the Reporting of Observational Studies in Epidemiology tool 11 as this was considered most appropriate as the majority of studies were observational. It was not possible to use the recommended quality checklists for prognostic factor research, 12 eg, Quality in Prognosis Studies, 13 REporting recommendations for tumour MARKer prognostic studies (REMARK), 14 nor diagnostic studies Quality Assessment of Diagnostic Accuracy Studies 15 due to the large number of included studies that were not focused on the prognostic value of factors.
Assessment of heterogeneity
Forest plots were created to visually assess outliers and any unusual results were investigated with sensitivity analysis. The I 2 value was calculated for each meta-analysis. A measurement !50% indicated a substantial risk of heterogeneity. Where there was significant heterogeneity (visually or statistically), a sensitivity analysis was performed to assess the effect.
Assessment of reporting bias
In meta-analyses with >10 studies, a funnel plot was generated using the metafunnel command 16 in Stata (Stata, Release 13.1 StataCorp, College Station, TX), and Egger test was performed using the metabias command, 17 and with a significance level of 10%.
Data synthesis
Meta-analyses were reported at the perpregnancy level, not per fetus, for 2 reasons. Firstly, reporting at the fetus level would require an adjustment for clustering, but more importantly when considering prognostic factors for pregnancy-related diseases in multiple pregnancy, any change in management due to a prognostic test/model would be affected at the pregnancy level.
Data synthesis for factors reported as means and medians
For continuous data with a normal distribution, medians were converted to means to enable meta-analysis. When the interquartile range (IQR) was reported, the SD was calculated as IQR/ 1.35. 18 When medians were not reported with IQRs, the mean and SD was estimated. 19 For nonnormally distributed data (nuchal translucency [NT] discordance, CRL discordance and parity) where only the median was reported, it was not possible to convert the median to means, therefore these results could not be included in meta-analysis.
Data synthesis for association
Data were extracted to create 2 Â 2 contingency tables to compare: (1) disease vs no disease but where other complications may be present, and (2) disease vs normal pregnancy where no complications were present at all. For outcomes with >3 included studies, odds ratios (OR) were calculated using the metan command 20 in Stata, and pooled using the DerSimonianLaird random effects model to account for expected clinical heterogeneity. ORs >2 were considered to demonstrate a moderate association, 21 thus the prognostic ability of the factor was subsequently investigated. For continuous variables reported as, or converted into, means and SDs, the standardized mean difference was calculated using the metan command 20 in Stata. Standardized mean difference !0.5 was considered to demonstrate a moderate effect 22 and the prognostic ability of the factor was investigated.
Data synthesis for prognostic ability
Bivariate meta-analysis using a random effects model was performed in analyses of >3 studies to calculate the summary sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio using the metandi command 23 in Stata. Hierarchical summary receiver operating characteristic (ROC) curves were generated using the metandiplot command 23 to represent the level of uncertainty of sensitivity and specificity for bivariate analyses. Univariate analysis was carried out for analyses with <4 studies using software (MetaDiSc, v1.4116; http://www.hrc.es/investigacion/ metadisc_en.htm), 24 with symmetrical summary ROC curves generated. We added 0.5 to cells of 0 to perform univariate meta-analysis, but not bivariate meta-analysis, due to the necessary use of different computer programs. When a prognostic factor was found to have a moderate association with the outcome, the predictive ability was investigated and the posttest probability using Fagan nomogram, 25 which accounts for pretest probability, was calculated.
Results

Study selection
Electronic searches identified 2439 citations of which 1312 titles were excluded after review of titles and 743 after abstract review. 384 full articles were assessed (Figure 1 ) of which 48 studies 26e73 met the inclusion criteria equating to the evaluation of 5365 MC twin pregnancies. See the Supplementary Table for the study characteristics of all included studies. Studies that met the inclusion criteria but were unable to be included in meta-analysis are described in Appendix B, as are individual prognostic factors that were unable to be included in meta-analysis.
Study characteristics
The Supplementary Table displays the study characteristics of the included Systematic Reviews ajog.org articles and details regarding individual measurements such as definitions of growth restriction. The ultrasound measurements reported were: NT, CRL, the presence of a reversed wave in the ductus venosus, and umbilical venous flow velocity. The maternal characteristics reported in eligible studies were: maternal age, ethnicity, BMI, parity, and smoking. Mode of conception and fetal gender was also reported. The firsttrimester biomarkers reported were all from maternal serum, and included: thyroid-stimulating hormone, free thyroxine, b-human chorionic gonadotropin (hCG), and pregnancy-associated plasma protein (PAPP-A). The most frequently investigated outcomes were TTTS (n ¼ 31 studies), AGR (n ¼ 14 studies), and PGR (n ¼ 12 studies).
Risk of bias of included studies
Most studies were not designed for the recruitment of participants to examine first-trimester potential prognostic factors. The different aspects of the Strengthening the Reporting of Observational Studies in Epidemiology classification are demonstrated in Figure 2 . Of note is that the studies were poor at stating how they addressed missing data, and which data were missing. One aspect of the study design that may increase the risk of heterogeneity was that different control groups were used: (1) MC twin pregnancies with no maternal or fetal complications, (2) MC twins with no fetal complications, (3) other MC twin pregnancies in the study that did not have the condition being examined but did have other MC complications. For the growth restriction outcomes, studies were classified according to the time that the growth measurement was performed, meaning that 5 studies, 32, 37, 41, 71, 72 despite calling their outcome IUGR, were included in the PGR group as their definition was based on birthweights, not antenatal ultrasound measurements. In calculating discordance between EFW or birthweight all studies used the larger measure as the denominator. Four studies included in the PGR meta-analyses only measured abnormal growth by birthweight discordance (Moriichi et al, 56 Stagnati et al, 62 Sun et al, 64 and Zhao et al 72 ) meaning that both babies may have weighed >10th centile. All other studies that reported abnormal growth as an outcome had to have at least 1 fetus/baby <10th centile, except for 3 studies that were not able to be included in meta-analyses due to being the only studies that measured their potential prognostic factor. 42, 45, 52 Not all the participants in the study by Murakami et al 57 had delivered at the time the study was published, therefore only those who had delivered were included in our analysis. Only 1 funnel plot and Egger test was required, which did suggest significant publication bias in the maternal age and TTTS analysis (available on request from authors).
Synthesis of results
Meta-analysis could be performed for the following prognostic factors:
Ultrasound measurements: NT >95th centile in one/both fetuses, NT discordance !20%, CRL discordance !10%. Maternal characteristics: age, ethnicity, BMI, parity, smoking, mode of conception, fetal gender.
In total, 20 separate meta-analyses were performed; of these, 3 demonstrated a moderate association (OR, >2), but none demonstrated a prognostic ability for any outcome under (Figure 3, A) . Bivariate meta-analysis results are in the Table. The posttest probability of a positive result was 0.22 (95% CI, 0.13e0.35), and a negative result was 0.14 (95% CI, 0.13e0.15), assuming pretest probability of 0.176 based on a prevalence of 15%. See Figure 3 , B, for the hierarchical summary ROC that shows reasonable specificity but poor sensitivity. (Figure 4, A) . Univariate meta-analysis results are in the Table. The posttest probability of a positive result was 0.28 (95% CI, 0.20e0.38), and a negative result was 0.13 (95% CI, 0.12e0.15), assuming pretest probability of 0.176 based on a prevalence of 15%. See Figure 4 , B, for the summary ROC.
CRL discordance ‡10% and TTTS
Maternal ethnicity and TTTS
An OR >1 indicated a higher risk of TTTS if the woman was white, and an OR <1 indicated a higher risk of TTTS if the woman was non-white. A significant association between maternal ethnicity and TTTS was found (OR, 2.12 [95% CI, 1.17e3.83], I 2 ¼ 0.0%, 5 studies, 467 pregnancies) ( Figure 5, A) . Bivariate metaanalysis results are in the Table. The posttest probability of a positive result was 0.17 (95% CI, 0.15e0.19), and a negative result was 0.10 (95% CI, 0.06e0.16), assuming pretest probability of 0.176 based on a prevalence of 15%. See Figure 5 , B, for hierarchical summary ROC that shows moderate sensitivity but poor specificity.
Comment
Main findings This is the first systematic review to look at first-trimester potential prognostic factors for growth restriction in MC twins, and explore maternal characteristics and firsttrimester maternal serum biomarkers as prognostic factors for TTTS. Although a significant association was found between NT >95th centile in one/both fetuses and TTTS, and CRL discordance !10% and TTTS, both demonstrated poor individual prognostic ability. A moderate significant association between maternal ethnicity and TTTS was found, with white women more likely to develop TTTS, but as there is no plausible biological mechanism for this association, this may reflect the lack of diversity within the study populations and publication bias. The other first-trimester ultrasound 48 only reported the median and not the IQR these studies could not be combined in metaanalysis, but this warrants further investigation due to the small study sizes and biological plausibility of bhCG and PAPP-A being implicated in TTTS as markers of placental function.
Strengths and limitations
A major strength of our study was to include all possible prognostic factors and perform a robust statistical analysis to look at the association and prognostic ability of the factors. The search strategy was as inclusive as possible, and there was no limit on language. It was particularly important to look at modifiable factors such as smoking and maternal BMI where lifestyle changes may be associated with a lower risk for adverse outcome.
One limitation of our review was the different definitions that studies used for their control groups, variables, and outcomes, which is why we did not stipulate the individual definitions rigidly prior to commencing the search. This was an issue for growth restriction as there is currently no validated standard definition of abnormal growth in MC twins. Consequently, the included studies defined growth restriction in a myriad of ways: abdominal circumference 5th centile, EFW <10th centile, EFW <5th centile, estimated fetal weight discordance (EFWD) >20%, low birthweight <10th centile, low birthweight <5th centile, BWD !20%, BWD !25%, and in different combinations of one or both twins when not measuring discordance, all of which can be associated with adverse outcome. This issue has attempted to be investigated by a recent Delphi consensus looking at selective fetal growth restriction in twin pregnancy, 74 and will be addressed by the creation of a core outcome set for selective fetal growth restriction in twin pregnancies, 75 which is due to be completed by August 2019. In this systematic review, we attempted to address the problem by creating different growth-restriction groups so as to be as inclusive as possible. The AGR group reflects real life and is on what obstetricians base their management. However, ultrasound scanning and calculation of EFWD only has a moderate ability to detect BWD with a recent systematic review reporting a sensitivity of 65.4% (95% CI, 57.9e72.3) and specificity of 90.8% (95% CI, 87.1e93.5%) for EFWD !20% predicting BWD !20%, although the analysis does include NT>95th centile in one/both fetuses and twin-twin transfusion syndrome A, Forest plot of association between nuchal translucency (NT) >95th centile in one/both fetuses and twin-twin transfusion syndrome (TTTS). 29, 39, 60, 63 B, Hierarchical summary receiver operating characteristic curves (HSROC) for NT >95th centile in one/both fetuses and TTTS studies. Global summary of prognostic factor performance by plotting mean sensitivity against reversed mean specificity produced by bivariate analysis. Ellipses represent 95% confidence intervals (CI) of mean sensitivities and specificities and 95% prediction region. Closer values are to top left corner, greater accuracy of prognostic factor.
OR, odds ratio. 78 However, most studies in our search that reported growth based on postnatal measures used BWD as opposed to low birthweight, therefore it was decided to include BWD in our systematic review. The use of intertwin growth discordance in isolation, whether EFWD or BWD, also presents the problem of missing pregnancies where both twins are growth restricted, but irrespective of choice of definition and cut-offs, all growth outcomes have the common problem of not being based on specific twin growth charts, which until July 2017 did not exist. Since performing this review, twin growth charts have been launched in the United Kingdom to enable more accurate assessment of twin fetal growth. 79 Another issue was that of cut-offs for the variables as the cut-offs have not been adequately validated and may not be appropriate for the study's patient population, or the conditions being explored. We had planned to compare: (1) disease vs no disease but where other complications may be present, and (2) disease vs normal pregnancy where no complications were present at all; however, as most studies used the former control group, we were unable to perform a separate analysis for the latter comparison. This has only allowed us to evaluate the ability of each potential prognostic factor to predict a specific condition, and not any condition (and thus we cannot predict the chance of the pregnancy being completely "normal"). CRL discordance >10% and twin-twin transfusion syndrome A, Forest plot of association between crown-rump length discordance (CRLD) >10% and twin-twin transfusion syndrome (TTTS). 37, 39, 43 B, Summary receiver operating characteristic curves (SROC) for CRLD !10% and TTTS.
AUC, area under the curve; CI, confidence interval; OR, odds ratio; Q*, Index Q*; SE(AUC), standard error of the area under the curve; SE(Q*), standard of the index Q*.
Mackie. Early prognostic factors in monochorionic twin pregnancy. Am J Obstet Gynecol 2018. Mackie. Early prognostic factors in monochorionic twin pregnancy. Am J Obstet Gynecol 2018.
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Comparison with existing literature A systematic review evaluating prognostic factors up to 16 weeks for TTTS has recently been published, however, they only looked at ultrasound prognostic markers, and their search was up to April 2014. 80 They stated that an increased risk of TTTS was associated with intertwin NT discrepancy, NT >95th centile, and CRL discrepancy, but similar to our results, the prognostic ability of these factors was low. In addition to our inclusion of other MC twin complications, there are other differences between our reviews, including that Stagnati et al 80 did not exclude pregnancies with chromosomal/structural anomalies that affect first-trimester ultrasound measurements. D'Antonio et al 81 performed a systematic review examining the ability of firsttrimester CRL discordance !10% to predict BWD !20%, preterm birth, fetal anomalies, IUFD, and neonatal death, and found it also had a low prognostic ability for all outcomes.
Conclusions and implications
The main clinical implication of the results of our systematic review is that they support the guidance from RCOG that "screening for TTTS by first-trimester NT measurements should not be offered." 5 Although we have shown significant associations between firsttrimester variables and subsequent pregnancy outcome, the prognostic ability of each individual variable is poor, thus the results do not suggest their use to screen MC pregnancies in clinical practice.
However, we have identified a gap in knowledge that has implications for research as most studies able to be included in the systematic review were not designed with the intention of assessing first-trimester prognostic factors for subsequent outcomes in MC twins. Consequently, Optimal Management of Monochorionic Twins (OMMIT) (ISRCTN13114861), a large cohort study, was purposefully designed by us to investigate potential prognostic factors and explore novel prognostic markers that have not previously been evaluated including alpha-fetoprotein, PAPP-A, and soluble fms-like tyrosine kinase-1. 82 To avoid the problem of using nonvalidated cut-offs, variables should be kept continuous and not dichotomized.
Conclusion
We have investigated the association and prognostic ability of first-trimester factors, including maternal characteristics, associated with TTTS, growth restriction, and IUFD. We have found that it is not currently possible to predict adverse outcomes in MC twin pregnancies, and have revealed a lack of research investigating first-trimester biomarkers in MC twin pregnancies.
Different assessment methods and definitions of each variable and outcome were an issue and this highlights the need for a large cohort study to evaluate these factors.
- FIGURE 5 Maternal ethnicity and twin-twin transfusion syndrome A, Forest plot of association between maternal ethnicity and twin-twin transfusion syndrome (TTTS). 26, 31, 47, 53, 68 B, Hierarchical summary receiver operating characteristic curves (HSROC) for maternal ethnicity and TTTS studies. Global summary of prognostic factor performance by plotting mean sensitivity against reversed mean specificity produced by bivariate analysis. Ellipses represent 95% confidence intervals (CI) of mean sensitivities and specificities and 95% prediction region. Closer values are to top left corner, greater accuracy of prognostic factor. OR >1 indicated a higher risk of TTTS if the woman was White, and an OR >1 indicated a higher risk of TTTS if the woman was White, and an OR <1 indicated a higher risk of TTTS if the woman was non-White.
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